TickerFacts.

Company research / BON

Bon Natural Life Ltd (BON)

Build a valuation ↗↓ Download CSV

CIK 0001816815 · Nasdaq · Medicinal Chemicals & Botanical Products

  • Sector Manufacturing
  • Fiscal year ends Sep 30

For the year ended 2025-09-30, Bon Natural Life Ltd reported revenue of $18.67M. Revenue fell 21.7% from the prior annual period.

Key ratios (year ended 2025-09-30)

20.8%
Gross margin
-8.7%
Operating margin
-10.7%
Net margin
-3.4%
Return on year-end equity
-21.7%
Revenue growth (YoY)

Beyond the statements

Follow the company.

Explore new filings, reported insider transactions and company relationships.

Open company research ↗

Latest selected filing: Form 6-K (current report) · 2026-09-23

Annual financials

Annual flows and balances are grouped by their actual period end. Select a figure to open its SEC filing. n/a means a matching observation is unavailable. Free cash flow is operating cash flow minus capital expenditures, and EBITDA is operating income plus depreciation and amortization, for the same period, computed by TickerFacts.

Stock splits: 1-for-10, first reflected in a filing dated 2025-01-28. Figures are as filed: per-share figures and share counts last reported before a split are on the old share basis, so changes and growth rates across a split are not shown. Splits are read from the filings' own restatements, so a share conversion in a merger or reorganization shows up the same way.

Period ended2025-09-302024-09-302023-09-302022-09-302021-09-302020-09-302019-09-30
Revenue$18.67M$23.84M$29.52M$29.91M$25.49M$18.22M$16.40M
Cost of Revenue$14.79M$16.73M$20.68M$20.48M$18.38M$13.02M$11.11M
Gross Profit$3.88M$7.11M$8.84M$9.42M$7.11M$5.20M$5.28M
R&D Expense$754.2K$1.62M$298.5K$424.6K$249.1K$205.4K$522.9K
Operating Income-$1.62M$1.87M$5.94M$6.60M$5.40M$3.47M$3.18M
Depreciation & Amortization$1.09M$1.11M$949.5K$215.6Kn/an/an/a
EBITDA-$535.6K$2.98M$6.89M$6.82Mn/an/an/a
Net Income-$1.99M$398.2K$4.60M$6.24M$4.59M$3.03M$2.57M
EPS (Diluted)-$0.72$4.14$124.92$7.43$0.68$0.58$0.50
Total Assets$85.19M$61.77M$46.56M$37.26M$36.41M$25.20Mn/a
Total Liabilities$27.19M$17.42M$10.57M$7.16M$9.88M$14.18Mn/a
Long-Term Debt$1.92M$1.43M$1.29M$2.33M$2.62M$3.71Mn/a
Shareholders' Equity$58.00M$44.35M$35.98M$30.09M$26.53M$11.02M$7.26M
Cash & Equivalentsn/a$80.5Kn/an/an/an/an/a
Operating Cash Flow$141.1K-$7.72M-$616.9K-$187.1K$4.05M$2.64M$7.10M
Capital Expenditures$6.8K$7.0K$61.9K$27.7K$51.9K$31.9K$213.6K
Free Cash Flow$134.3K-$7.73M-$678.8K-$214.8K$4.00M$2.61M$6.89M
Shares Outstandingn/a3.97M1.17M8.40M8.33M5.80Mn/a
Weighted Average Diluted Shares2.76M96.1K36.8K839.6K6.71M5.21M5.17M
EPS (Basic)-$0.72$4.17$125.72$7.47$0.69$0.58$0.50

Price chart

Chart and quotes by TradingView. Exchange coverage and delays vary.

Open chart on TradingView